Featured Research

from universities, journals, and other organizations

Reducing Antibiotic Use Lowers Rates Of Drug-resistant Bacteria

Date:
September 2, 2005
Source:
Infectious Diseases Society of America
Summary:
Fewer antibiotic prescriptions leads to fewer "superbugs." That's the take-home message behind a new study in the Oct. 15 issue of Clinical Infectious Diseases, now available online. The study found that reducing antibiotic use for pediatric respiratory tract infections resulted in lower rates of carriage of drug-resistant bacteria.

Drug-resistantbacteria, commonly called “superbugs,” are fast becoming a problem dueto overuse and inappropriate prescribing of antibiotics. Streptococcuspneumoniae bacteria, also called pneumococci, are commonly found inchildren’s noses and throats, and can result in ear infections,sinusitis, pneumonia and even meningitis. Many pneumococcal infectionsare treated with penicillin, but resistance to the drug is making themicrobes more difficult to control.

Researchers in France testedtwo intervention methods intended to reduce the rate of carriage ofpenicillin-resistant pneumococci in kindergarteners. Theprescription-reduction method involved not prescribing antibiotics forrespiratory tract infections that were thought to be viral, sinceantibiotics work against bacteria, not viruses. The dose/durationmethod involved using only recommended doses of antibiotics for nolonger than 5 days. The researchers also targeted physicians,pharmacists, parents, and children in the groups receiving bothinterventions with an information campaign about antibiotic resistanceand appropriate antibiotic use. A control group of children and theirdoctors received no specific information about antibiotic use.

Thestudy was conducted from January through May of 2000. By the end of thestudy, antibiotic use had declined by more than 15 percent in bothintervention groups, compared to less than 4 percent in the controlgroup. Although colonization by regular pneumococci was higher in theintervention groups than in the control group, colonization bypenicillin-resistant pneumococci was lower in the intervention groupsthan in the control group. The prescription-reduction group saw thegreatest decline in penicillin-resistant colonization (from 53 percentto 35 percent), and the dose/duration group dropped from 55 percent to44 percent. The control group remained nearly unchanged. This suggeststhat reduced antibiotic pressure allows drug-susceptible bacteria tore-establish themselves as dominant colonizers of the respiratory tract.

Implementingintervention programs that are “focused on populations most exposed toantibiotics”--that is, children--is the first step in reining insuperbugs, said lead author Didier Guillemot, MD, PhD, of InstitutPasteur.

Intervention methods such as reducing the number ofprescriptions and, when ordered, the dose and duration of antibiotics,“can induce significant and rapid reductions” of penicillin-resistantpneumococcal colonization in areas that have high rates ofdrug-resistant bacteria, according to the study. In essence, doctorscan make their own jobs easier by prescribing antibiotics morejudiciously, thus slowing the spread of superbugs.

###

Foundedin 1979, Clinical Infectious Diseases publishes clinical articles twicemonthly in a variety of areas of infectious disease, and is one of themost highly regarded journals in this specialty. It is published underthe auspices of the Infectious Diseases Society of America (IDSA).Based in Alexandria, Virginia, IDSA is a professional societyrepresenting about 8,000 physicians and scientists who specialize ininfectious diseases. For more information, visit www.idsociety.org.


Story Source:

The above story is based on materials provided by Infectious Diseases Society of America. Note: Materials may be edited for content and length.


Cite This Page:

Infectious Diseases Society of America. "Reducing Antibiotic Use Lowers Rates Of Drug-resistant Bacteria." ScienceDaily. ScienceDaily, 2 September 2005. <www.sciencedaily.com/releases/2005/09/050902071201.htm>.
Infectious Diseases Society of America. (2005, September 2). Reducing Antibiotic Use Lowers Rates Of Drug-resistant Bacteria. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2005/09/050902071201.htm
Infectious Diseases Society of America. "Reducing Antibiotic Use Lowers Rates Of Drug-resistant Bacteria." ScienceDaily. www.sciencedaily.com/releases/2005/09/050902071201.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins